Wave Pharmaceuticals Ltd Financials
Company Logo

Wave Pharmaceuticals Ltd Financial Statement

Wave Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Wave Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual2.15
Operating Expenses Annual1.81
Operating Profit Annual0.40
Interest Annual0.01
Depreciation0.05
Net Profit Annual0.24
Tax Annual0.10

Wave Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.59
Cash Flow from Operations0.10
Cash Flow from Investing-0.95
Cash Flow from Financing1.82
Cash Flow at the End1.55

Wave Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)18.60
PBIT Margin (%)16.28
PBT Margin (%)-1,611.63
Net PROFIT Margin (%)11.16
Return On Networth / Equity (%)5.30
Return On Networth /Employed (%)2.81
Return On Assets (%)2.46
Total Debt / Equity (X)3.98
Asset Turnover Ratio (%)0.22

Wave Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual4.75
Total Current Assets Annual5.63
Non Current Assets Annual7.97
Total Shareholders Funds Annual2.54
Total Assets Annual13.60

Wave Pharmaceuticals Ltd Earning Calls

No Data Availabe

FAQS on Wave Pharmaceuticals Ltd Financials

As of Jul 19, 2025, Wave Pharmaceuticals Ltd has a market capitalization of - Cr. Value Research classifies it as a Mega-Cap company.

Yes, Wave Pharmaceuticals Ltd is not with a debt-to-equity ratio of .

In FY 2024 , Wave Pharmaceuticals Ltd recorded a total revenue of approximately - Cr marking a significant milestone in the company's financial performance.

Wave Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising annually..

Wave Pharmaceuticals Ltd's current PE ratio is .

Wave Pharmaceuticals Ltd's ROCE averaged NaN% from the FY ending March NaN to NaN, with a median of NaN%. It peaked at -Infinity% in March NaN, reflecting strong capital efficiency over the period..

Wave Pharmaceuticals Ltd's latest EBIT is Rs. - Cr, surpassing the average EBIT of Rs. - Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions